Opportunity Information: Apply for USAID M OAA GH 08 923
Apply for USAID M OAA GH 08 923
- The Agency for International Development in the health sector is offering a public funding opportunity titled "Tuberculosis Research to enhance the Prevention, Detection Management of TB cases." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Apr 28, 2008 and posted on Apr 28, 2008.
- Applicants must submit their applications by Jun 27, 2008. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $80,000,000.00 in funding.
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Tuberculosis Research to enhance the Prevention, Detection Management of TB cases" (Funding Opportunity Number USAID M OAA GH 08 923) is a USAID global health grant competition aimed at strengthening the evidence base for tuberculosis control worldwide. The core purpose is to stimulate high-impact TB research that improves how existing tools are used, accelerates the development and evaluation of new technologies and approaches, and, importantly, ensures that research results are translated into global policy and practice. In other words, the opportunity is not only about generating data, but also about moving findings into the real-world decision-making systems that guide national TB programs and international TB guidance.
This opportunity was issued by the U.S. Agency for International Development (USAID) under CFDA 98.001, "USAID Foreign Assistance for Programs Overseas," and falls within the Health funding activity category. The instrument type is a Cooperative Agreement, which typically signals a more hands-on partnership model where USAID anticipates substantial involvement during implementation. That can include collaboration on technical direction, coordination with other USAID-supported TB investments, and active engagement around dissemination and uptake of results. The opportunity category is listed as Mandatory, indicating it was part of a required or structured funding initiative rather than a purely discretionary solicitation.
A notable feature of this announcement is its scale and structure: the award floor and award ceiling are both listed as $80,000,000, suggesting USAID anticipated a single award at that amount rather than multiple smaller awards. The presence of a cost sharing or matching requirement means applicants were expected to contribute non-federal resources or document matching support, which is often used to extend impact, demonstrate commitment, and leverage complementary funding or in-kind contributions (such as personnel time, lab capacity, data systems, or partner support). Eligibility is described as unrestricted, meaning that, unless limited elsewhere in the full text, the competition was generally open to a wide range of applicant organizations (for example, universities, NGOs, private firms, research institutes, or consortia), provided they met any detailed eligibility conditions in the full announcement.
The program focus, based on the title and description, centers on research that enhances TB prevention, detection, and case management. That scope commonly includes topics such as improving diagnostic strategies and access to rapid testing, optimizing treatment regimens and adherence approaches, strengthening models of care delivery, addressing TB and HIV co-infection or drug-resistant TB challenges, and evaluating implementation strategies that make interventions more effective in real health systems. The emphasis on optimizing "existing and new technologies and approaches" implies USAID was interested both in getting more value from current TB tools and in validating emerging innovations. The additional emphasis on translating findings into global policy implies the program valued operational relevance, strong dissemination plans, and engagement with stakeholders who influence guidelines and standards (for example, national ministries of health, global technical bodies, and implementing partners).
Key dates show this was a time-limited 2008 competition. The posting and creation date were April 28, 2008, with an original and current closing date of June 27, 2008, and an archive date of July 27, 2008. For applicants at the time, that would have meant preparing a substantial technical and cost proposal within roughly a two-month window. The listed contact for access issues with the full announcement was Ousmane Faye, Agreement Specialist, reachable by phone at (202) 712 0832 or email at ofaye@usaid.gov.
Overall, this opportunity reflects a large-scale USAID investment designed to push TB research beyond academic outputs and into practical, policy-relevant results. The combination of an $80 million cooperative agreement, required cost share, and explicit policy translation goals points to an initiative intended to shape TB programming at global and national levels by generating evidence, testing approaches in real-world settings, and actively supporting the incorporation of successful findings into guidance and implementation.
Frequently Asked Questions (FAQs)
What is the official title of this funding opportunity?
The opportunity is titled "Tuberculosis Research to enhance the Prevention, Detection Management of TB cases."
What is the Funding Opportunity Number?
The Funding Opportunity Number is USAID M OAA GH 08 923.
Who is the issuing agency?
The issuing agency is the U.S. Agency for International Development (USAID).
What CFDA number is associated with this opportunity?
This opportunity is listed under CFDA 98.001, "USAID Foreign Assistance for Programs Overseas."
What funding activity category does this opportunity fall under?
The funding activity category is Health.
What is the main purpose of this grant competition?
The core purpose is to strengthen the evidence base for tuberculosis (TB) control worldwide by stimulating high-impact TB research that improves how existing tools are used, accelerates the development and evaluation of new technologies and approaches, and ensures research findings are translated into global policy and practice.
Is this opportunity only about generating research data?
No. In addition to generating evidence, the opportunity emphasizes moving findings into real-world decision-making systems that guide national TB programs and international TB guidance.
What type of funding instrument is being used?
The instrument type is a Cooperative Agreement.
What does a Cooperative Agreement imply about USAID's role?
A Cooperative Agreement typically signals a more hands-on partnership model where USAID anticipates substantial involvement during implementation. Based on the description provided, this can include collaboration on technical direction, coordination with other USAID-supported TB investments, and active engagement around dissemination and uptake of results.
What is the opportunity category?
The opportunity category is listed as Mandatory, indicating it was part of a required or structured funding initiative rather than a purely discretionary solicitation.
What is the award amount?
The award floor is $80,000,000 and the award ceiling is also $80,000,000.
Does having the same award floor and ceiling suggest anything about the expected number of awards?
Yes. With both the floor and ceiling listed as $80,000,000, the announcement suggests USAID anticipated a single award at that amount rather than multiple smaller awards.
Is cost sharing or matching required?
Yes. The opportunity indicates a cost sharing or matching requirement, meaning applicants were expected to contribute non-federal resources or document matching support.
What kinds of contributions might count toward cost sharing or matching?
The description notes that matching support can involve complementary funding or in-kind contributions such as personnel time, laboratory capacity, data systems, or partner support.
Who is eligible to apply?
Eligibility is described as unrestricted. This generally indicates the competition was open to a wide range of applicant organizations (for example, universities, NGOs, private firms, research institutes, or consortia), provided they met any detailed eligibility conditions in the full announcement.
What is the program focus or research scope?
The focus is on research that enhances TB prevention, detection, and case management, with an emphasis on both optimizing existing tools and evaluating new technologies and approaches.
What are examples of research areas that fit within the described scope?
Based on the description, the scope commonly includes improving diagnostic strategies and access to rapid testing, optimizing treatment regimens and adherence approaches, strengthening care delivery models, addressing TB and HIV co-infection or drug-resistant TB challenges, and evaluating implementation strategies that make interventions more effective in real health systems.
Does the opportunity prioritize translating research findings into policy?
Yes. A stated emphasis is ensuring that research results are translated into global policy and practice, implying strong interest in operational relevance, dissemination plans, and engagement with stakeholders who influence guidelines and standards.
Which stakeholders are implied as important for policy translation and uptake?
The description points to engagement with groups that influence guidance and standards, such as national ministries of health, global technical bodies, and implementing partners.
When was the opportunity posted?
The posting date (and creation date) is April 28, 2008.
What was the application closing date?
The original and current closing date is June 27, 2008.
When was the opportunity archived?
The archive date is July 27, 2008.
Is this a current opportunity or a historical one?
Based on the provided dates (posted in 2008, closed in 2008, archived in 2008), this appears to be a time-limited 2008 competition rather than an open, currently accepting opportunity.
How much time was available between posting and closing?
From April 28, 2008 to June 27, 2008, applicants had roughly two months to prepare and submit a technical and cost proposal.
Who is the listed contact for access issues with the full announcement?
The listed contact is Ousmane Faye, Agreement Specialist.
How can the listed contact be reached?
Phone: (202) 712 0832. Email: ofaye@usaid.gov.
What is the overall intent of the initiative as described?
The initiative is described as a large-scale USAID investment intended to push TB research beyond academic outputs and into practical, policy-relevant results, shaping TB programming at global and national levels by generating evidence, testing approaches in real-world settings, and actively supporting incorporation of successful findings into guidance and implementation.
Browse more opportunities from the same agency: Agency for International Development
Browse more opportunities from the same category: Health
Next opportunity: Immunological Assays (ELISA) for the Detection of Ricin, Abrin, and Botulinum Toxins (IADRABT)
Previous opportunity: Projects of National Significance Family Support 360 for Military Families
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for USAID M OAA GH 08 923
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (USAID M OAA GH 08 923) also looked into and applied for these:
| Funding Opportunity |
|---|
| Urban Indian Health Programs Apply for HHS 2008 IHS UIHP 0001 Funding Number: HHS 2008 IHS UIHP 0001 Agency: Indian Health Service Category: Health Funding Amount: $8,500,000 |
| Maternal and Child Health Apply for USAID CAMBODIA 442 08 006 RFA Funding Number: USAID CAMBODIA 442 08 006 RFA Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $27,500,000 |
| Public Private Alliances to Improve Womens Health by Addressing Primary Causes of Morbidity and Mortality during Reproductive Years Apply for USAID M OAA GRO EGAS 08 108 Funding Number: USAID M OAA GRO EGAS 08 108 Agency: Agency for International Development Category: Health Funding Amount: $274,000 |
| Uganda Stop Malaria Project Apply for 617 08 010 Funding Number: 617 08 010 Agency: Uganda USAID Kampala Category: Health Funding Amount: $45,000,000 |
| Injury Control Support for Region 5 Apply for DTNH22 08 R 00136 Funding Number: DTNH22 08 R 00136 Agency: DOT/National Highway Traffic Safety Administration Category: Health Funding Amount: $239,750 |
| Roads to a Healthy Future Apply for RFA DRAFT 623 EA 08 030 Funding Number: RFA DRAFT 623 EA 08 030 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Population Health Environment Technical Leadership Cooperative Agreement Apply for USAID M OAA GH 08 1112 Funding Number: USAID M OAA GH 08 1112 Agency: Agency for International Development Category: Health Funding Amount: $7,500,000 |
| Knowledge for Health (K4H) Leader with Associate Cooperative Agreement Apply for USAID M OAA GH 08 1111 Funding Number: USAID M OAA GH 08 1111 Agency: Agency for International Development Category: Health Funding Amount: $34,600,000 |
| Medicaid Infrastructure Grants Apply for HHS 2009 CMS CONT MIG Funding Number: HHS 2009 CMS CONT MIG Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| The Medicaid Infrastructure Grant Apply for HHS 2009 CMS MIG 0001 Funding Number: HHS 2009 CMS MIG 0001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $750,000 |
| Reproductive Health/Family Planning and Child Survival Services Apply for 617 08 14 Funding Number: 617 08 14 Agency: Uganda USAID Kampala Category: Health Funding Amount: $39,000,000 |
| Roads to a Healthy Future Apply for 623 EA 08 038 Funding Number: 623 EA 08 038 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $109,000,000 |
| Health Management Education Activity in Georgia Apply for 114 08 008 Funding Number: 114 08 008 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $350,000 |
| Health Systems Strengthening Apply for USAID CAMBODIA 442 08 008 RFA Funding Number: USAID CAMBODIA 442 08 008 RFA Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $36,000,000 |
| Nursing Program, Schools of Nursing Apply for HHS 2008 IHS NU 0001 Funding Number: HHS 2008 IHS NU 0001 Agency: Indian Health Service Category: Health Funding Amount: $337,000 |
| Harnessing Inflammation for Reconstruction of Oral and Craniofacial Tissues (R01) Apply for RFA DE 09 001 Funding Number: RFA DE 09 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Harnessing Inflammation for Reconstruction of Oral and Craniofacial Tissues (R21) Apply for RFA DE 09 002 Funding Number: RFA DE 09 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Immune Defense Mechanisms at the Mucosa (R21) Apply for RFA AI 08 020 Funding Number: RFA AI 08 020 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Public Health Nursing Apply for HHS 2008 IHS PHN 0001 Funding Number: HHS 2008 IHS PHN 0001 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| SSA Protection and Advocacy Program Apply for SSA OAG 08 2 Funding Number: SSA OAG 08 2 Agency: ODISP OESP Category: Health Funding Amount: $439,035 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "USAID M OAA GH 08 923", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.